PATENT CLAIM ANALYSIS

Application Number: 15951580
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "647000"]

Abstract:
Methods of treating developmental encephalopathies by administering compositions including ketamine, norketamine, or other derivatives of ketamine, or a pharmaceutically acceptable salt of any of the foregoing, are provided. The methods and compositions may be used to treat conditions such as Dravet syndrome.

Claim (Index 21):
The method of  claim 1 , wherein the ketamine or the ketamine derivative is administered to the patient that provides an in vivo plasma profile comprising a AUC 0-\u221e  less than about 100 ng\u00b7hr/ml.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 91.0
- Lexical Diversity: 1.26316
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15728695', '15341784', '14876110', '15493374', '15191068']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7339671944839893
- 35 USC 102 Novelty (BERT): 0.5065060279284788
- Combined Prediction Score: 0.7112210778284382
- Mean Citation Score: 206.100366
- Max Citation Score: 231.02005
- Similarity Product: 143.01804902644454

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test